Pharmacists' experiences on adverse drug reaction: 10 years later

被引:2
|
作者
Karuppannan, Mahmathi [1 ]
Rizal, Nur Azzrin Nisha Mohamad [2 ]
Wong, Kok-Thong [3 ]
Ali, Salmiah Mohd [4 ]
Ting, Kang-Nee [3 ]
Boardman, Helen [5 ]
机构
[1] Univ Teknol MARA UiTM Cawangan Selangor, Fac Pharm, Dept Pharm Practice, Puncak Alam Campus, Shah Alam, Malaysia
[2] Hosp Sultanah Nora Ismail, Batu Pahat, Malaysia
[3] Univ Nottingham Malaysia, Sch Pharm, Semenyih, Malaysia
[4] Asian Metropolitan Univ, Kuala Lumpur, Malaysia
[5] Univ Nottingham, Sch Pharm, Div Pharm Practice & Policy, Nottingham, England
关键词
adverse drug reaction; pharmacists; community pharmacists; reporting ADRs; survey; COMMUNITY PHARMACISTS; KNOWLEDGE; PHARMACOVIGILANCE; PREVALENCE; ATTITUDES; ADMISSION; BARRIERS;
D O I
10.3389/fphar.2022.932942
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adverse drug reaction (ADR) is one of the leading public health concerns associated with high mortality rate. Healthcare professionals, particularly pharmacists, have a significant role in monitoring and preventing ADRs. This study was conducted on Malaysian Pharmaceutical Society (MPS) pharmacists who worked at the hospitals, health clinics, and community pharmacies to determine if pharmacists' experiences on ADRs are still the same 10 years later. In 2010, a postal survey and in 2020, an online survey were conducted among these pharmacists. A total of 472 pharmacists and 208 participated in 2010 and 2020, respectively. About 82% and 90% of hospital/health clinic pharmacists (HCPs) observed an ADR over the last 6 months in 2010 and 2020, while 60% and 100% community pharmacists in 2010 and 2020 observed an ADR, respectively. Perindopril was the top drug (HCPs: p = 0.657; CPs: p = 0.98), and rash was the top ADR reported by the pharmacists in both years (HCPs: p < 0.001; CPs: p = 0.679). The most common actions taken by HCPs in 2010 were to report the ADR (p = 0.343), while in 2020, most HCPs explained to patients regarding the reaction (p = 0.061), which was also the same in the CP group in 2020 (p = 0.958). The top factor encouraging ADR reporting in both years and both pharmacist groups was the high degree of severity of the reaction (HCPs: p < 0.001; CPs: p = 0.769). While the top factors discouraging ADR reporting were a lack of information from the affected patients (HCPs: p = 0.2; CPs: p = 0.656), reaction is widely known (HCPs: p = 0.001; CPs: p = 0.144) and uncertainty of the causal relationship (HCPs: p = 0.169; CPs: p = 0.609). Majority of the pharmacists agreed that severe reactions should be reported (HCPs: p = 0.158; CPs: p = 0.501) and the main aim for reporting is to measure the incidence of ADRs (HCPs: p = 0.148; CPs: p = 0.762). Despite being able to identify ADRs during the daily practice, many pharmacists especially community pharmacists are not reporting them. There is a misconception on the purpose of reporting ADRs. An interventional program and ADR reporting training would be a useful step in improving ADR reporting practice.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] ADVERSE DRUG REACTION REPORTING AND PHARMACISTS
    FINCHAM, JE
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1989, 14 (02) : 79 - 81
  • [2] ADVERSE DRUG REACTION MONITORING BY WARD PHARMACISTS
    HARDMAN, C
    LLOYD, B
    JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1982, 7 (01): : 71 - 73
  • [3] THE ROLE OF PHARMACISTS IN ADVERSE DRUG REACTION REPORTING
    ROBERTS, PI
    WOLFSON, DJ
    BOOTH, TG
    DRUG SAFETY, 1994, 11 (01) : 7 - 11
  • [4] Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia
    Mahmoud, Mansour Adam
    Alswaida, Yazeed
    Alshammari, Thamir
    Khan, Tahir Mehmood
    Alrasheedy, Alian
    Hassali, Mohamad Azmi
    Aljadhey, Hisham
    SAUDI PHARMACEUTICAL JOURNAL, 2014, 22 (05) : 411 - 418
  • [5] Hospital pharmacists' role in adverse drug reaction reporting
    Westergren, Tone
    EJHP PRACTICE, 2010, 16 (04): : 10 - 11
  • [7] Adverse drug reaction reporting: an opportunity to expand the role of pharmacists
    Shalansky, Stephen
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2018, 71 (04): : 225 - 226
  • [8] Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting
    Green, CF
    Mottram, DR
    Rowe, PH
    Pirmohamed, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (01) : 81 - 86
  • [9] Adverse Drug Reaction Reporting: Opportunities to Increase Pharmacists' Role
    Shalansky, Stephen
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2018, 71 (04): : 223 - 224
  • [10] Characteristics and quality of adverse drug reaction reports by pharmacists in Norway
    Gedde-Dahl, Ane
    Harg, Pernille
    Stenberg-Nilsen, Hanne
    Buajordet, Marit
    Granas, Anne Gerd
    Horn, Anne Marie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (09) : 999 - 1005